To amend chapter 89 of title 5, United States Code, to ensure program integrity, transparency, and cost savings in the pricing and contracting of prescription drug benefits under the Federal Employees Health Benefits Program.
The bill’s titles are written by its sponsor.
Sponsor and status
Sponsor. Representative for Massachusetts's 8th congressional district. Democrat.
Last Updated: Mar 21, 2013
Length: 19 pages
113th Congress (2013–2015)
This bill was introduced on March 21, 2013, in a previous session of Congress, but it did not receive a vote.
Although this bill was not enacted, its provisions could have become law by being included in another bill. It is common for legislative text to be introduced concurrently in multiple bills (called companion bills), re-introduced in subsequent sessions of Congress in new bills, or added to larger bills (sometimes called omnibus bills).
3 Cosponsors (3 Democrats)
What legislators are saying
“Lynch Introduces FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act”
— Rep. Stephen Lynch [D-MA8] (Sponsor) on Mar 22, 2013
Jan 21, 2010
Earlier Version — Introduced
This activity took place on a related bill, H.R. 4489 (111th).
Mar 9, 2011
Earlier Version — Introduced
This activity took place on a related bill, H.R. 979 (112th).
Mar 21, 2013
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.
H.R. 1367 (113th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
Bills numbers restart every two years. That means there are other bills with the number H.R. 1367. This is the one from the 113th Congress.
This bill was introduced in the 113th Congress, which met from Jan 3, 2013 to Jan 2, 2015. Legislation not passed by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
GovTrack.us. (2022). H.R. 1367 — 113th Congress: FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act. Retrieved from https://www.govtrack.us/congress/bills/113/hr1367
“H.R. 1367 — 113th Congress: FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act.” www.GovTrack.us. 2013. January 19, 2022 <https://www.govtrack.us/congress/bills/113/hr1367>
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act, H.R. 1367, 113th Cong. (2013).
|title=H.R. 1367 (113th)
|accessdate=January 19, 2022
|author=113th Congress (2013)
|date=March 21, 2013
|quote=FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.